Stuart Therapeutics Announces Issuance of U.S. Patent Covering Ophthalmic Anterior Segment Disorders
/PRNewswire/ -- Stuart Therapeutics, Inc. (Stuart), a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of...
Source: prnewswire.com